CSF2RB and hematopoietic and lymphoid system neoplasm: The role of CSF2RB and other similar receptors in hematological or blood cancers was established in recent decades through several scientific research studies using hematological cell lines, primary cells, animal models, and human patients (Watanabe-Smith et al., 2016; Liongue and Ward, 2014; Maxson et al., 2013).